CytomX Therapeutics Accounts Receivable (Quarterly) Analysis

CytomX Therapeutics Inc (CTMX)

1.905 -0.10 (-4.75%) USD | NASDAQ | May 17, 16:00

1.89 -0.02 (-0.79%) After-Hours: 20:00

Accounts Receivable (Quarterly) Chart

Historical Accounts Receivable (Quarterly) Data

View and export this data back to 2014. Upgrade now.

Date	Value
March 31, 2024	13.18M
December 31, 2023	3.432M
September 30, 2023	2.419M
June 30, 2023	1.903M
March 31, 2023	1.09M
December 31, 2022	35.99M
September 30, 2022	1.712M
June 30, 2022	1.014M
March 31, 2022	1.016M
December 31, 2021	0.79M
September 30, 2021	0.887M
June 30, 2021	0.931M
March 31, 2021	0.756M
December 31, 2020	0.798M
September 30, 2020	0.543M
June 30, 2020	0.206M
March 31, 2020	130.01M
December 31, 2019	0.013M
September 30, 2019	0.007M

Date	Value
June 30, 2019	10.00M
March 31, 2019	0.044M
December 31, 2018	0.097M
September 30, 2018	0.056M
June 30, 2018	25.14M
March 31, 2018	0.081M
December 31, 2017	10.14M
September 30, 2017	40.18M
June 30, 2017	0.158M
March 31, 2017	0.213M
December 31, 2016	2.159M
September 30, 2016	0.24M
June 30, 2016	0.285M
March 31, 2016	0.316M
December 31, 2015	0.372M
September 30, 2015	0.406M
June 30, 2015	0.631M
December 31, 2014	1.875M

Accounts Receivable Definition

Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.

Read full definition.

Accounts Receivable (Quarterly) Range, Past 5 Years

0.007M

Minimum

Sep 2019

130.01M

Maximum

Mar 2020

10.33M

Average

1.015M

Median

Accounts Receivable (Quarterly) Benchmarks